Emerging roles of A-kinase anchoring proteins in cardiovascular pathophysiology

被引:52
作者
Diviani, Dario [1 ]
Reggi, Erica [1 ]
Arambasic, Miroslav [1 ]
Caso, Stefania [1 ]
Maric, Darko [1 ]
机构
[1] Fac Biol & Med, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2016年 / 1863卷 / 07期
关键词
A kinase anchoring protein (AKAP); Protein kinase A (PKA); Signaling; Cardiac remodeling; Cardiomyocyte; Vascular smooth muscle cells; CARDIAC MYOCYTE HYPERTROPHY; ARTERIAL SMOOTH-MUSCLE; AKAP-LBC; PKA PHOSPHORYLATION; SIGNALING COMPLEX; HEART-FAILURE; PHOSPHATIDYLINOSITOL; 4-PHOSPHATE; MICROTUBULE DYNAMICS; INSULIN-RESISTANCE; REGULATORY SUBUNIT;
D O I
10.1016/j.bbamcr.2015.11.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Heart and blood vessels ensure adequate perfusion of peripheral organs with blood and nutrients. Alteration of the homeostatic functions of the cardiovascular system can cause hypertension, atherosclerosis, and coronary artery disease leading to heart injury and failure. A-kinase anchoring proteins (AKAPs) constitute a family of scaffolding proteins that are crucially involved in modulating the function of the cardiovascular system both under physiological and pathological conditions. AKAPs assemble multifunctional signaling complexes that ensure correct targeting of the cAMP-dependent protein kinase (PKA) as well as other signaling enzymes to precise subcellular compartments. This allows local regulation of specific effector proteins that control the function of vascular and cardiac cells. This review will focus on recent advances illustrating the role of AKAPs in cardiovascular pathophysiology. The accent will be mainly placed on the molecular events linked to the control of vascular integrity and blood pressure as well as on the cardiac remodeling process associated with heart failure. This article is part of a Special Issue entitled: Cardiomyocyte Biology: Integration of Developmental and Environmental Cues in the Heart edited by Marcus Schaub and Hughes Abriel. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:1926 / 1936
页数:11
相关论文
共 138 条
[1]
The A-kinase anchor protein AKAP121 is a negative regulator of cardiomyocyte hypertrophy [J].
Abrenica, Bernard ;
AlShaaban, Mohamed ;
Czubryt, Michael P. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 46 (05) :674-681
[2]
The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates α1 adrenergic receptor-induced cardiomyocyte hypertrophy [J].
Appert-Collin, Aline ;
Cotecchia, Susanna ;
Nenniger-Tosato, Monique ;
Pedrazzini, Thierry ;
Diviani, Dario .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (24) :10140-10145
[3]
The case for inhibiting p38 mitogen-activated protein kinase in heart failure [J].
Arabacilar, Pelin ;
Marber, Michael .
FRONTIERS IN PHARMACOLOGY, 2015, 6
[4]
Isoform-specific differences between the type Iα and IIα cyclic AMP-dependent protein kinase anchoring domains revealed by solution NMR [J].
Banky, P ;
Newlon, MG ;
Roy, M ;
Garrod, S ;
Taylor, SS ;
Jennings, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (45) :35146-35152
[5]
Dimerization/docking domain of the type Iα regulatory subunit of cAMP-dependent protein kinase -: Requirements for dimerization and docking are distinct but overlapping [J].
Banky, P ;
Huang, LJS ;
Taylor, SS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) :35048-35055
[6]
GLUCOSE-INDUCED ALTERATIONS OF CYTOSOLIC-FREE CALCIUM IN CULTURED RAT TAIL ARTERY VASCULAR SMOOTH-MUSCLE CELLS [J].
BARBAGALLO, M ;
SHAN, J ;
PANG, PKT ;
RESNICK, LM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :763-767
[7]
Vasoregulation by the β1 subunit of the calcium-activated potassium channel [J].
Brenner, R ;
Peréz, GJ ;
Bonev, AD ;
Eckman, DM ;
Kosek, JC ;
Wiler, SW ;
Patterson, AJ ;
Nelson, MT ;
Aldrich, RW .
NATURE, 2000, 407 (6806) :870-876
[8]
Selective versus nonselective β-blockade for heart failure therapy:: Are there lessons to be learned from the COMET trial? [J].
Bristow, MR ;
Feldman, AM ;
Adams, KF ;
Goldstein, S .
JOURNAL OF CARDIAC FAILURE, 2003, 9 (06) :444-453
[9]
The Rac and Rho hall of fame - A decade of hypertrophic signaling hits [J].
Brown, JH ;
Del Re, DP ;
Sussman, MA .
CIRCULATION RESEARCH, 2006, 98 (06) :730-742
[10]
The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure [J].
Brown, RD ;
Ambler, SK ;
Mitchell, MD ;
Long, CS .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :657-687